Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Laruel

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical Sciences|July 1, 1985
Amiodarone partitioning with phospholipid bilayers and erythrocyte membranesP Chatelain, R Laruel
Archives Internationales De Physiologie Et De Biochimie|September 1, 1973
[Phosphorylation of ribosomal proteins in eukaryotic cells: the effect of inhibitors of translation]J Werenne, R Laruel, A Laruel
Biochemical Pharmacology|May 1, 1987
Decrease in lipid mobility in rat erythrocyte membrane after amiodarone chronic treatmentP Chatelain, R Brotelle, R Laruel
Biochemical and Biophysical Research Communications|May 31, 1985
Effect of amiodarone on membrane fluidity and Na+/K+ ATPase activity in rat-brain synaptic membranesP Chatelain, R Laruel, M Gillard
Biochemical Pharmacology|April 15, 1989
Differential effects of amiodarone and propranolol on lipid dynamics and enzymatic activities in cardiac sarcolemmal membranesP Chatelain, R Laruel, P Vic, et al.
Biochemical Pharmacology|October 7, 1994
Interaction of the calcium antagonist fantofarone with phospholipids: electrostatic effectsP Chatelain, J R Matteazzi, R Laruel
Biochemical Pharmacology|April 1, 1992
Fluorescent studies on the interaction between a novel Ca2+ antagonist, SR 33557, and membrane lipidsP Chatelain, J R Matteazzi, R Laruel
Journal of Pharmaceutical Sciences|May 1, 1994
Binding of fantofarone, a novel Ca2+ antagonist, to serum albumin: a fluorescence studyP Chatelain, J R Matteazzi, R Laruel
Biochemical Pharmacology|September 15, 1986
Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization studyP Chatelain, J Ferreira, R Laruel, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranesP Nokin, M Clinet, P Beaufort, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|July 1, 1985
Amiodarone partitioning with phospholipid bilayers and erythrocyte membranesP Chatelain, R Laruel
Archives Internationales De Physiologie Et De Biochimie|September 1, 1973
[Phosphorylation of ribosomal proteins in eukaryotic cells: the effect of inhibitors of translation]J Werenne, R Laruel, A Laruel
Biochemical Pharmacology|May 1, 1987
Decrease in lipid mobility in rat erythrocyte membrane after amiodarone chronic treatmentP Chatelain, R Brotelle, R Laruel
Biochemical and Biophysical Research Communications|May 31, 1985
Effect of amiodarone on membrane fluidity and Na+/K+ ATPase activity in rat-brain synaptic membranesP Chatelain, R Laruel, M Gillard
Biochemical Pharmacology|April 15, 1989
Differential effects of amiodarone and propranolol on lipid dynamics and enzymatic activities in cardiac sarcolemmal membranesP Chatelain, R Laruel, P Vic, et al.
Biochemical Pharmacology|October 7, 1994
Interaction of the calcium antagonist fantofarone with phospholipids: electrostatic effectsP Chatelain, J R Matteazzi, R Laruel
Biochemical Pharmacology|April 1, 1992
Fluorescent studies on the interaction between a novel Ca2+ antagonist, SR 33557, and membrane lipidsP Chatelain, J R Matteazzi, R Laruel
Journal of Pharmaceutical Sciences|May 1, 1994
Binding of fantofarone, a novel Ca2+ antagonist, to serum albumin: a fluorescence studyP Chatelain, J R Matteazzi, R Laruel
Biochemical Pharmacology|September 15, 1986
Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization studyP Chatelain, J Ferreira, R Laruel, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranesP Nokin, M Clinet, P Beaufort, et al.
Pageof 2